AquaCelle® is a branded ingredient-delivery technology associated with Pharmako Biotechnologies. It is designed to support the delivery of selected lipophilic, or fat-soluble, ingredients through self-micro-emulsifying formulations.
Many lipophilic compounds have limited water dispersibility, which can create challenges when developing oral nutritional products, supplements, and other formulations. Specialised delivery systems can help address some of these formulation challenges by promoting dispersion of the ingredient in an aqueous environment.
The exact formulation, active ingredient, composition, and intended application depend on the specific AquaCelle® product. Buyers should identify the precise variant before relying on product-specific specifications or performance claims.
AquaCelle® is associated with self-micro-emulsifying delivery systems. These systems typically combine a lipophilic active ingredient with suitable formulation components that can facilitate dispersion when exposed to an aqueous environment.
Depending on the formulation, the system may form a fine oil-in-water dispersion under appropriate conditions. This can help address challenges associated with delivering selected poorly water-soluble ingredients.
The performance of a delivery system depends on its composition, the active ingredient, manufacturing process, and conditions of use. AquaCelle® should therefore be evaluated using documentation for the exact commercial product rather than treated as a single universal formulation.
Some ingredients have limited water solubility, which may complicate the development of consistent oral formulations. Delivery technologies can help formulators improve dispersion and manage the physical behaviour of such ingredients.
AquaCelle®-type systems may be considered when developing products containing selected lipophilic ingredients. However, improved dispersion does not automatically establish improved absorption, bioavailability, clinical efficacy, or therapeutic benefit. Such claims require appropriate product-specific evidence.
Depending on the specific AquaCelle® formulation and applicable regulations, possible development areas may include:
These are potential application categories, not confirmation that every AquaCelle® variant is suitable for every ingredient or dosage format.
Before selecting AquaCelle®, buyers should confirm the full product name, active ingredient, formulation type, physical form, ingredient declaration, and intended application.
Relevant technical information may include active content, dispersion characteristics, particle or droplet-size data where applicable, stability information, compatibility, recommended processing conditions, and shelf life. Product-specific data should be used to determine whether the system meets the requirements of the intended formulation.
Commercial buyers should request a current technical data sheet, certificate of analysis, ingredient composition, allergen statement, safety data sheet where applicable, stability data, and regulatory documentation for the exact product.
The relevant regulatory status depends on the active ingredient, other formulation components, intended use, and destination market. Do not assume that the brand name alone establishes approval for all applications.
Mediocon Inc. supports enquiries for pharmaceutical, nutraceutical, and specialty ingredients. Contact the team to confirm whether the required AquaCelle® variant is available and to request its technical documentation, manufacturer information, composition, and commercial details.
| Parameter | Specification |
|---|---|
| Identification | AquaCelle® |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying AquaCelle® Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our AquaCelle® Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance